Cas:322690-31-3 tert-Butyl 6-aminopyridin-2-ylcarbamate manufacturer & supplier

Chemical Name:tert-Butyl 6-aminopyridin-2-ylcarbamate

CAS.NO:322690-31-3

Synonyms:2-Methyl-2-propanyl (6-amino-2-pyridinyl)carbamate;tert-Butyl6-aminopyridin-2-ylcarbamate;2-Amino-6-(tert-butoxycarbonylamino)pyridine;2-amino-6-tert-butoxycarbonylaminopyridine;Carbamic acid, N-(6-amino-2-pyridinyl)-, 1,1-dimethylethyl ester;2-Amino-6-(Boc-amino)pyridine;tertbutylaminopyridinylcarbamate;AB2725;tert-Butyl (6-aminopyridin-2-yl)carbamate;Tert-butyl 6-aminopyridin-2-ylcarbamate

Molecular Formula:C₁₀H₁₅N₃O₂

Molecular Weight:209.245

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:307.1±27.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.587

PSA:77.24000

Exact Mass:209.116425

LogP:1.68

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Methyl-2-propanyl (6-amino-2-pyridinyl)carbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Tert-butyl 6-aminopyridin-2-ylcarbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-6-(Boc-amino)pyridine Use and application,Tert-butyl 6-aminopyridin-2-ylcarbamate technical grade,usp/ep/jp grade.

Related News: After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. tert-Butyl 6-aminopyridin-2-ylcarbamate manufacturer Secretary of Health Francisco Duque said authorities are working with the Chinese embassy to respectfully handle the remains of the man while following international protocol to contain the disease. tert-Butyl 6-aminopyridin-2-ylcarbamate supplier After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. tert-Butyl 6-aminopyridin-2-ylcarbamate vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. tert-Butyl 6-aminopyridin-2-ylcarbamate factory These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.